Response to post-axitinib treatment in patients with metastatic renal cell carcinoma
Crossref DOI link: https://doi.org/10.1186/s12885-016-2282-5
Published Online: 2016-03-29
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chittoria, Namita
Haddad, Housam
Elson, Paul
Tannir, Nizar M.
Wood, Laura S.
Dreicer, Robert
Garcia, Jorge A.
Rini, Brian I.
Jonasch, Eric
License valid from 2016-03-29